Your heart after menopause: the risk that changes shape

Three shifts arrive together. Cholesterol patterns worsen, with the protective HDL drifting down and LDL up. Blood pressure tends to rise. And fat storage moves toward the middle, which is the metabolically active kind that raises cardiovascular and diabetes risk.

Any one alone is modest. Arriving together, across the same five to ten years, they are why the decade after menopause is when quiet numbers start deserving attention, even in women who have never had a bad reading in their lives.

Blood pressure and a lipid panel. Both are free or nearly free in both countries: blood pressure at any pharmacy or with an inexpensive home cuff, and lipids through your doctor or at an annual physical. HbA1c, the three-month blood sugar average, earns third place on the list, because diabetes risk moves with the same midlife shifts.

The habit that beats any single reading is owning your numbers over time. A reading a year, kept somewhere you can see, turns a drift into a conversation years before it turns into an event. Our Testing page covers the wider panel question honestly; for the heart specifically, these two or three numbers do most of the work.

The unglamorous things, with unusually strong evidence. Movement most days, with both the brisk kind that raises your heart rate and the strength kind that keeps muscle. Not smoking, which remains the single largest modifiable factor. A Mediterranean-pattern way of eating, one of the few dietary patterns with hard trial evidence for fewer cardiac events. Alcohol on the lower side of what your current habit probably is. Sleep, which this site takes seriously for exactly this kind of reason.

Where the numbers have already drifted, medication is not defeat. Blood pressure treatment and statins are among the best-evidenced drugs in all of medicine, and for women whose risk warrants them they prevent exactly the events this page is about. That is a numbers conversation to have with a clinician, ideally with your own trend line in hand.

The timing story matters here more than anywhere. Started under 60 or within ten years of the final period, HRT looks neutral to mildly favourable for the heart in the modern analyses. Started well beyond that window, particularly as tablets, it may add risk. That is precisely the timing conversation covered in our HRT pages.

What no professional body supports is taking HRT solely to protect the heart. It is not a cardiac drug. The honest framing: heart protection is a possible quiet passenger of a decision made for other reasons at the right time, and the levers with the strongest cardiac evidence remain the ones in the section above.